T1	CHEM 103 134	sustituto de volumen plasmático
#1	AnnotatorNotes T1	C3536887; Plasma Volume Expander; Pharmacologic Substance
T2	ANAT 124 134	plasmático
#2	AnnotatorNotes T2	C0032105; Plasma; Body Substance
T3	CHEM 168 171	HES
#3	AnnotatorNotes T3	C0020352; hetastarch; Organic Chemical · Pharmacologic Substance
T4	PROC 189 206	cirugía abdominal
#4	AnnotatorNotes T4	C0198482; Operation on abdominal region; Therapeutic or Preventive Procedure
T5	PROC 229 339	Estudio prospectivo, aleatorizado, doble-ciego, internacional y multicéntrico sobre la seguridad y la eficacia
T6	PROC 46 96	Estudio para investigar la seguridad y la eficacia
T7	CHEM 380 383	HES
#5	AnnotatorNotes T7	C0020352; hetastarch; Organic Chemical · Pharmacologic Substance
T9	PROC 451 468	cirugía abdominal
#6	AnnotatorNotes T9	C0198482; Operation on abdominal region; Therapeutic or Preventive Procedure
T10	DISO 527 538	hipovolemia
#7	AnnotatorNotes T10	C0085608; Decreased blood volume; Finding | C0546884; Hypovolemia; Finding
T11	DISO 549 565	sangrado intenso
#8	AnnotatorNotes T11	C0333276; Acute hemorrhage; Pathologic Function
T12	PROC 577 594	cirugía abdominal
#9	AnnotatorNotes T12	C0198482; Operation on abdominal region; Therapeutic or Preventive Procedure
T13	PROC 632 643	Tratamiento
#10	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	DISO 647 658	hipovolemia
#11	AnnotatorNotes T14	C0085608; Decreased blood volume; Finding | C0546884; Hypovolemia; Finding
T15	PROC 659 676	cirugía abdominal
#12	AnnotatorNotes T15	C0198482; Operation on abdominal region; Therapeutic or Preventive Procedure
T16	PROC 839 855	test de embarazo
#13	AnnotatorNotes T16	C0032976; Pregnancy Tests; Diagnostic Procedure
T17	ANAT 874 879	suero
#14	AnnotatorNotes T17	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T18	PROC 903 920	cirugía abdominal
#15	AnnotatorNotes T18	C0198482; Operation on abdominal region; Therapeutic or Preventive Procedure
T19	ANAT 958 964	sangre
#16	AnnotatorNotes T19	C0005767; Blood; Body Substance
T20	DISO 1051 1068	Hipersensibilidad
#17	AnnotatorNotes T20	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T21	CHEM 1107 1117	excipiente
#18	AnnotatorNotes T21	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T22	DISO 1183 1189	Sepsis
#19	AnnotatorNotes T22	C0243026; Sepsis; Disease or Syndrome
T23	DISO 1190 1200	Quemaduras
#20	AnnotatorNotes T23	C0006434; Burn injury; Injury or Poisoning
T24	DISO 1201 1216	Trastorno renal
#21	AnnotatorNotes T24	C0022658; Kidney Diseases; Disease or Syndrome
T25	PROC 1237 1263	terapia de reemplazo renal
#22	AnnotatorNotes T25	C0206074; Renal Replacement Therapy; Therapeutic or Preventive Procedure
T26	ANAT 1258 1263	renal
#23	AnnotatorNotes T26	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T27	ANAT 1306 1314	cerebral
#24	AnnotatorNotes T27	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T28	DISO 1394 1410	Hiperhidratación
#25	AnnotatorNotes T28	C0392689; Overhydration; Pathologic Function | C0546817; Fluid overload; Pathologic Function
T29	DISO 1411 1425	Deshidratación
#26	AnnotatorNotes T29	C0011175; Dehydration; Disease or Syndrome
T30	DISO 1426 1440	Edema pulmonar
#27	AnnotatorNotes T30	C0034063; Pulmonary Edema; Pathologic Function
T31	DISO 1442 1475	Insuficiencia cardiaca congestiva
#28	AnnotatorNotes T31	C0018802; Congestive heart failure; Disease or Syndrome
T32	DISO 1476 1489	Hipernatremia
#29	AnnotatorNotes T32	C0020488; Hypernatremia; Disease or Syndrome
T33	DISO 1497 1510	Hipercloremia
#30	AnnotatorNotes T33	C0085679; Hyperchloremia; Disease or Syndrome
T34	DISO 1518 1532	Hiperpotasemia
#31	AnnotatorNotes T34	C0020461; Hyperkalemia; Finding
T35	DISO 1533 1553	Alcalosis metabólica
#32	AnnotatorNotes T35	C0220983; Metabolic alkalosis; Disease or Syndrome
T36	ANAT 1562 1570	hepática
#33	AnnotatorNotes T36	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T37	DISO 1594 1606	Coagulopatía
#34	AnnotatorNotes T37	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T38	PROC 1628 1649	trasplante de órganos
#35	AnnotatorNotes T38	C0029216; Organ Transplantation; Therapeutic or Preventive Procedure
T39	PROC 1684 1716	ensayos clínicos de intervención
T40	ANAT 197 206	abdominal
#36	AnnotatorNotes T40	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T41	CHEM 358 378	Hydro-xyethyl starch
T42	CHEM 403 425	solución electrolítica
T43	DISO 492 525	Disminución del volumen sanguíneo
T44	ANAT 459 468	abdominal
#37	AnnotatorNotes T44	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T45	ANAT 516 525	sanguíneo
#38	AnnotatorNotes T45	C0005767; Blood; Body Substance
T46	ANAT 585 594	abdominal
#39	AnnotatorNotes T46	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T47	ANAT 667 676	abdominal
#40	AnnotatorNotes T47	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T48	ANAT 866 871	orina
#41	AnnotatorNotes T48	C0042036; Urine; Body Substance
T49	ANAT 911 920	abdominal
#42	AnnotatorNotes T49	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T50	DISO 938 964	pérdida esperada de sangre
T51	CHEM 1074 1092	sustancias activas
T52	ANAT 1165 1173	corporal
#43	AnnotatorNotes T52	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T53	ANAT 1211 1216	renal
#44	AnnotatorNotes T53	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T54	DISO 1280 1314	Hemorragia intracraneal o cerebral
T55	ANAT 1291 1303	intracraneal
#45	AnnotatorNotes T55	C0524466; Intracranial; Body Location or Region
T56	PROC 1347 1392	admitidos en la unidad de cuidados intensivos
T57	ANAT 1456 1464	cardiaca
#46	AnnotatorNotes T57	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T58	PROC 992 1016	Consentimiento informado
#47	AnnotatorNotes T58	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T59	ANAT 1642 1649	órganos
#48	AnnotatorNotes T59	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T60	CHEM 1731 1743	medicamentos
#49	AnnotatorNotes T60	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T61	CHEM 148 166	hydroxyethyl-stach
#50	AnnotatorNotes T61	C0020352; hetastarch; Organic Chemical · Pharmacologic Substance
T62	ANAT 1432 1440	pulmonar
#51	AnnotatorNotes T62	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T63	DISO 1554 1593	Función hepática gravemente deteriorada
T64	Date 13 17	2016
T65	LIVB 176 185	pacientes
#52	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	Form 346 354	solución
#53	AnnotatorNotes T66	C1382100; Solution Dosage Form; Biomedical or Dental Material
T67	Form 403 411	solución
#54	AnnotatorNotes T67	C1382100; Solution Dosage Form; Biomedical or Dental Material
T68	LIVB 429 438	pacientes
#55	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T71	LIVB 712 746	Pacientes adultos de ambos géneros
#56	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T72	Age 747 763	> 40 y ≤ 85 años
T73	LIVB 778 800	mujeres en edad fértil
#57	AnnotatorNotes T73	C4324275; Woman of childbearing potential; Population Group
T74	Age 789 800	edad fértil
T75	Neg_cue 824 832	negativo
T77	LIVB 881 890	Pacientes
#58	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T79	Duration 1272 1279	crónica
#59	AnnotatorNotes T79	C0205191; chronic; Temporal Concept
T80	LIVB 1315 1333	Pacientes críticos
#60	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T81	LIVB 1614 1623	Pacientes
#61	AnnotatorNotes T81	C0030705; Patients; Patient or Disabled Group
T82	DEVI 1746 1766	dispositivos médicos
#62	AnnotatorNotes T82	C0025080; Medical Devices; Medical Device
T83	PHYS 847 855	embarazo
#63	AnnotatorNotes T83	C0032961; Pregnancy; Organism Function
T84	PHYS 1543 1553	metabólica
#64	AnnotatorNotes T84	C0025519; Metabolism; Organism Function
T85	Dose 355 357	6%
T8	PROC 1160 1173	Peso corporal
#65	AnnotatorNotes T8	C2985231; Body Weight Measurement; Diagnostic Procedure
T69	PROC 974 984	Estado ASA
#66	AnnotatorNotes T69	C4751522; Assessment using American Society of Anesthesiologists Physical Status Classification System; Health Care Activity
T70	CHEM 1125 1159	productos médicos en investigación
#67	AnnotatorNotes T70	C0013230; Investigational New Drugs; Pharmacologic Substance
A1	Population_data T71 Age
A2	Population_data T73 Age
A3	Assertion T83 Negated
A4	Status T20 History_of
#68	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
#69	AnnotatorNotes T41	C0020352; hetastarch; Organic Chemical · Pharmacologic Substance
#70	AnnotatorNotes T42	C3853872; electrolyte solution; Pharmacologic Substance 
#71	AnnotatorNotes T43	C0085608; Decreased blood volume; Finding
#72	AnnotatorNotes T51	C0574031; Biologically Active Substance; Biologically Active Substance
#73	AnnotatorNotes T54	C0553692; Brain hemorrhage; Pathologic Function | C2937358; Cerebral Hemorrhage; Pathologic Function + C0151699; Intracranial Hemorrhage; Pathologic Function
#74	AnnotatorNotes T56	C5419131; Intensive Care Unit Stay; Health Care Activity
#75	AnnotatorNotes T39	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
R1	Combined_with Arg1:T1 Arg2:T61	
R2	Combined_with Arg1:T1 Arg2:T3	
R3	Experiences Arg1:T65 Arg2:T1	
R4	Experiences Arg1:T65 Arg2:T4	
R5	Location_of Arg1:T40 Arg2:T4	
R6	Has_Drug_Form Arg1:T41 Arg2:T66	
R7	Has_Drug_Form Arg1:T7 Arg2:T66	
R8	Has_Dose_or_Strength Arg1:T41 Arg2:T85	
R9	Has_Dose_or_Strength Arg1:T7 Arg2:T85	
R10	Has_Drug_Form Arg1:T42 Arg2:T67	
R11	Experiences Arg1:T68 Arg2:T41	
R12	Experiences Arg1:T68 Arg2:T7	
R13	Experiences Arg1:T68 Arg2:T42	
R14	Experiences Arg1:T68 Arg2:T9	
R15	Location_of Arg1:T44 Arg2:T9	
R18	Causes Arg1:T11 Arg2:T43	
R19	Causes Arg1:T11 Arg2:T10	
R20	Overlap Arg1:T11 Arg2:T12	
R21	Location_of Arg1:T46 Arg2:T12	
T76	Quantifier_or_Qualifier 595 605	programada
#76	AnnotatorNotes T76	C0205539; Scheduled - procedure status; Qualitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T76	
R23	Location_of Arg1:T47 Arg2:T15	
T78	Quantifier_or_Qualifier 677 685	electiva
#77	AnnotatorNotes T78	C0439608; elective; Temporal Concept
R24	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T78	
R25	Has_Age Arg1:T71 Arg2:T72	
R26	Has_Age Arg1:T73 Arg2:T74	
R27	Experiences Arg1:T73 Arg2:T16	
R28	Negation Arg1:T75 Arg2:T83	
R29	Location_of Arg1:T48 Arg2:T16	
R30	Location_of Arg1:T17 Arg2:T16	
R31	Location_of Arg1:T49 Arg2:T18	
R32	Experiences Arg1:T77 Arg2:T18	
T86	Quantifier_or_Qualifier 921 929	electiva
#78	AnnotatorNotes T86	C0439608; elective; Temporal Concept
R33	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T86	
R34	Location_of Arg1:T19 Arg2:T50	
T87	Result_or_Value 965 973	≥ 500 ml
R35	Has_Result_or_Value Arg1:T50 Arg2:T87	
R36	Overlap Arg1:T18 Arg2:T50	
T88	Result_or_Value 985 991	II-III
R37	Has_Result_or_Value Arg1:T69 Arg2:T88	
R38	Causes Arg1:T51 Arg2:T20	
R39	Causes Arg1:T21 Arg2:T20	
R40	Causes Arg1:T70 Arg2:T20	
R41	Location_of Arg1:T52 Arg2:T8	
T89	Result_or_Value 1174 1182	≥ 140 kg
R42	Has_Result_or_Value Arg1:T8 Arg2:T89	
R43	Location_of Arg1:T53 Arg2:T24	
R44	Location_of Arg1:T26 Arg2:T25	
R45	Has_Duration_or_Interval Arg1:T25 Arg2:T79	
T90	Result_or_Value 1230 1233	≥ 1
R46	Has_Result_or_Value Arg1:T24 Arg2:T90	
T91	Quantifier_or_Qualifier 1264 1269	aguda
#79	AnnotatorNotes T91	C0439557; Acute phase; Temporal Concept
R47	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T91	
R48	Location_of Arg1:T27 Arg2:T54	
R49	Location_of Arg1:T55 Arg2:T54	
R50	Experiences Arg1:T80 Arg2:T56	
R51	Location_of Arg1:T62 Arg2:T30	
R52	Location_of Arg1:T57 Arg2:T31	
R53	Location_of Arg1:T59 Arg2:T38	
R54	Experiences Arg1:T81 Arg2:T38	
R55	Location_of Arg1:T36 Arg2:T63	
T92	Observation 1650 1716	Participación simultánea en otros ensayos clínicos de intervención
T93	Quantifier_or_Qualifier 1607 1613	severa
#80	AnnotatorNotes T93	C1547227; Severe - Severity of Illness Code; Intellectual Product
R57	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T93	
T94	Quantifier_or_Qualifier 1511 1517	severa
#81	AnnotatorNotes T94	C1547227; Severe - Severity of Illness Code; Intellectual Product
R58	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T94	
T95	Quantifier_or_Qualifier 1490 1496	severa
#82	AnnotatorNotes T95	C1547227; Severe - Severity of Illness Code; Intellectual Product
R59	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T95	
R16	Experiences Arg1:T73 Arg2:T83	
A5	Experiencer T73 Patient
A6	Experiencer T71 Patient
A7	Experiencer T65 Patient
A8	Experiencer T68 Patient
A9	Experiencer T77 Patient
A10	Experiencer T80 Patient
A11	Experiencer T81 Patient
A12	Status T12 Future
T96	Result_or_Value 814 832	resultado negativo
R17	Has_Result_or_Value Arg1:T16 Arg2:T96	
